Basaglar and Swelling face - a phase IV clinical study of FDA data

Summary:

Swelling face is reported as a side effect among people who take Basaglar (insulin glargine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Swelling face when taking Basaglar. It is created by eHealthMe based on reports of 19,751 people who have side effects when taking Basaglar from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Swelling face?

Swelling face is found to be associated with 1,900 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Swelling face.

On Jul, 06, 2026

19,751 people reported to have side effects when taking Basaglar.
Among them, 31 people (0.16%) have Swelling face.

Among these 31 people:

How long have people been on Basaglar when they have Swelling face? *

What is the gender of people who have Swelling face when taking Basaglar? *

female: 72.41 %
male: 27.59 %

What is the age of people who have Swelling face when taking Basaglar? *

What are other drugs people take besides Basaglar? *

What are other side effects people have besides Swelling face? *

Rashes (redness): 6 people, 19.35%
Lip Swelling: 5 people, 16.13%
Peripheral Swelling: 4 people, 12.90%
Swollen Tongue (swelling of tongue): 4 people, 12.90%
Blood Glucose Increased: 4 people, 12.90%
Pain: 3 people, 9.68%
Eye Swelling: 3 people, 9.68%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 9.68%
Hypoglycemia (low blood sugar): 3 people, 9.68%
Itching: 3 people, 9.68%

What are the existing conditions these people have? *

Type 2 Diabetes: 8 people, 25.81%
Diabetes: 6 people, 19.35%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.45%
Type 1 Diabetes: 1 person, 3.23%
Sleep Disorder: 1 person, 3.23%
Pain: 1 person, 3.23%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 3.23%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 3.23%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 3.23%
High Blood Pressure: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and have Swelling face?

- Check whether Swelling face is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Basaglar:

Basaglar (19,807 reports)

Swelling face treatments and more:

Swelling face (70,017 reports)

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling face:

Swelling face (1,900 drugs)

Browse all the conditions that are associated with Swelling face:

Swelling face (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine (the active ingredients of Basaglar) and Basaglar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.